Funny how when we get momentous news, all of a sud
Post# of 72440
Let me remind everyone: the company is moving ahead dramatically with the sachet formulation of Brilacidin-OM which will enable the Phase 3 trial to proceed. That trial should go very quickly.
And, as Ultimate pointed out, it is possible that the company may be able to let patients use this soon, if the compassionate-use provisions are hammered out.